{
  "docId": "019de074-ca9a-70d9-9ba2-1d5f94361fe0",
  "docSlug": "6d754588aa25b32079af055d51113b03",
  "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
  "authorId": "aeglea-biotherapeutics",
  "authorName": "Aeglea BioTherapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 36,
  "pageCount": 38,
  "prevPage": 35,
  "nextPage": 37,
  "slideType": "appendix_methodology",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "The slide uses a process flow diagram to illustrate the clinical trial structure.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-ca9a-70d9-9ba2-1d5f94361fe0/36",
  "deckHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0",
  "deckJsonHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0.json",
  "deckAnchorHref": "/decks/019de074-ca9a-70d9-9ba2-1d5f94361fe0#slide-36",
  "components": [
    {
      "bbox": {
        "h": 0.21,
        "w": 0.89,
        "x": 0.105,
        "y": 0.285
      },
      "kind": "diagram",
      "text": "Flowchart showing patient enrollment, 2:1 randomization, treatment arms (Pegzilarginase vs Placebo), and long-term extension.",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "15e7d3f2-d4a7-4415-ada3-e2ec5f7acbbc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.44,
        "x": 0.068,
        "y": 0.615
      },
      "kind": "list",
      "text": "Key Endpoints: Primary (Plasma arginine reduction), Secondary (GMFM-E, 2-Minute Walk Test)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "38197ddc-de50-4e45-9f4c-478ebf7f1d3c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.475,
        "x": 0.455,
        "y": 0.615
      },
      "kind": "list",
      "text": "Analysis: Reduction of plasma arginine, Continuous analysis, Improvement compared to placebo",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "da6d8093-b786-448f-ba9c-1d43eface93f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.875,
        "x": 0.062,
        "y": 0.865
      },
      "kind": "source-note",
      "text": "*Dosing is weekly and, if needed, dose is modified based on plasma arginine levels with maintenance of blinding. †The first 8 weeks of the open-label extension will be blinded...",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f11ca6ca-382e-4dd1-bb70-699a2887c152",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.864,
        "x": 0.068,
        "y": 0.195
      },
      "kind": "title",
      "text": "Double-blind portion of trial complete – topline data announced December 2021",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3c4ec7da-2f01-4d97-a7c1-ea969647f963",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.398,
        "x": 0.068,
        "y": 0.045
      },
      "kind": "title",
      "text": "PEACE Phase 3 Study Design",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "494100e2-8cc8-4c87-99d9-16a145f8cd79",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "clinical-trial-design",
      "slug": null,
      "matchId": "22805c8b-39b3-4be6-90be-010daf20de4c",
      "evidence": "Standardized representation of patient cohorts, randomization, and study arms.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 38,
      "from": 3,
      "beatId": "e469074b-5500-4414-8b81-ef0652ee8a7d",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Traction",
      "beatSlug": null,
      "evidence": "Slides 3-38 present various traction metrics, including clinical trial results and financial summaries",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}